Logo
x

Search

Subscribe Now

All Posts by Date

PharmaShots Interview: Lumen's Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19

PharmaShots Interview: Lumen's Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment f...

  • June 26, 2020
Top COVID-19 Deals (Part III): Biopharma and Govt. Institutions

Top COVID-19 Deals (Part III): Biopharma and Govt. Institutions

  • June 26, 2020
AbbVie Signs an Exclusive Research and Option to License Agreement with Sosei Heptares Targeting Inflammatory and Autoimmune Diseases

AbbVie Signs an Exclusive Research and Option to License Agreement with Sosei Heptares Targeting Inflammatory and Autoimmune Disea...

  • June 26, 2020
Zogenix's Fintepla (fenfluramine) Receives the US FDA's Approval for the Treatment of Seizures Associated with Dravet Syndrome

Zogenix's Fintepla (fenfluramine) Receives the US FDA's Approval for the Treatment of Seizures Associated with Dravet Syndrome

  • June 26, 2020
EMA Anticipates the EC's Conditional Marketing Authorization for Gilead's Remdesivir in Coming Week

EMA Anticipates the EC's Conditional Marketing Authorization for Gilead's Remdesivir in Coming Week

  • June 26, 2020
Roche Launches uPath PD-L1 (SP263) Automated Digital Pathology Algorithm to Speed Up NSCLC Diagnosis

Roche Launches uPath PD-L1 (SP263) Automated Digital Pathology Algorithm to Speed Up NSCLC Diagnosis

  • June 26, 2020
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.